Cabot Co. (NYSE:CBT) Shares Acquired by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC lifted its holdings in shares of Cabot Co. (NYSE:CBT) by 19.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,058 shares of the specialty chemicals company’s stock after buying an additional 1,290 shares during the period. Los Angeles Capital Management LLC’s holdings in Cabot were worth $404,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Nisa Investment Advisors LLC lifted its position in Cabot by 100.0% in the second quarter. Nisa Investment Advisors LLC now owns 1,000 shares of the specialty chemicals company’s stock worth $57,000 after purchasing an additional 500 shares during the period. Parisi Gray Wealth Management acquired a new stake in Cabot in the second quarter worth approximately $69,000. Moors & Cabot Inc. acquired a new stake in Cabot in the third quarter worth approximately $215,000. Globeflex Capital L P lifted its position in Cabot by 29.6% in the second quarter. Globeflex Capital L P now owns 2,689 shares of the specialty chemicals company’s stock worth $153,000 after purchasing an additional 614 shares during the period. Finally, Carolina Wealth Advisors LLC lifted its position in Cabot by 21.3% in the third quarter. Carolina Wealth Advisors LLC now owns 3,040 shares of the specialty chemicals company’s stock worth $152,000 after purchasing an additional 533 shares during the period. Hedge funds and other institutional investors own 89.19% of the company’s stock.

Shares of NYSE:CBT opened at $61.06 on Friday. The company’s fifty day moving average is $56.61 and its two-hundred day moving average is $54.62. The company has a quick ratio of 0.79, a current ratio of 1.24 and a debt-to-equity ratio of 0.66. Cabot Co. has a 12-month low of $42.72 and a 12-month high of $65.25. The company has a market cap of $3.47 billion, a P/E ratio of 14.07 and a beta of 1.64.

Cabot (NYSE:CBT) last posted its quarterly earnings results on Sunday, November 7th. The specialty chemicals company reported $1.11 EPS for the quarter, beating the consensus estimate of $1.03 by $0.08. Cabot had a net margin of 7.33% and a return on equity of 28.15%. The business had revenue of $904.00 million for the quarter, compared to analysts’ expectations of $914.88 million. During the same period in the previous year, the company posted $0.68 EPS. Cabot’s revenue was up 37.2% on a year-over-year basis. Equities research analysts anticipate that Cabot Co. will post 5.38 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, December 10th. Stockholders of record on Friday, November 26th were issued a dividend of $0.37 per share. This is a boost from Cabot’s previous quarterly dividend of $0.35. This represents a $1.48 annualized dividend and a dividend yield of 2.42%. The ex-dividend date of this dividend was Wednesday, November 24th. Cabot’s payout ratio is currently 34.10%.

CBT has been the subject of a number of research analyst reports. Barclays upped their target price on Cabot from $70.00 to $72.00 and gave the stock an “overweight” rating in a research report on Friday, December 3rd. Deutsche Bank Aktiengesellschaft dropped their price target on Cabot from $62.00 to $60.00 and set a “hold” rating on the stock in a report on Tuesday, December 7th. Loop Capital upped their price target on Cabot from $81.00 to $86.00 and gave the company a “buy” rating in a report on Monday, November 29th. TheStreet raised Cabot from a “c” rating to a “b-” rating in a report on Monday, November 8th. Finally, UBS Group dropped their price target on Cabot from $75.00 to $70.00 and set a “buy” rating on the stock in a report on Tuesday, January 4th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $68.75.

Cabot Company Profile

Cabot Corp. is a global specialty chemicals and performance materials company. Its products are rubber and specialty grade carbon blacks, specialty compounds, fumed metal oxides, activated carbons, inkjet colorants, and aerogel. The company operates through the following segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions.

Featured Article: What moving averages are used to define a golden cross?

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBT).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.